Table 2.
Parameters of treatment efficacy for the total cohort and stratified by treatment modality.
| Total interventions (n = 54) | TBA only (n = 13) | IAN only (n = 35) | TBA + IAN (n = 6) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Parameter | pre | post | p | pre | post | p | pre | post | p | pre | post | p |
| ptiO2, mmHg | 15.0 ± 11.7 | 25.8 ± 15.5 | < 0.0001* | 21.5 ± 14.1 | 25.9 ± 17.8 | 0.48 | 13.3 ± 10.6 | 24.4 ± 14.5 | < 0.0001* | 11.1 ± 10.0 | 35.8 ± 16.8 | 0.07 |
| Lactate/Pyruvate ratio | 46.3 ± 27.5 | 31.0 ± 9.7 | 0.03* | 37.7 ± 14.1 | 28.2 ± 4.2 | 0.11 | 41.9 ± 23.1 | 31.1 ± 10.5 | 0.30 | 34.7 ± 10.8 | 29.2 ± 10.1 | 0.66 |
| TCD, cm/s | 139.0 ± 46.3 | 98.9 ± 29.6 | 0.02* | – | 128.9 ± 43.8 | 102.8 ± 31.7 | 0.16 | 152.0 ± 35.6 | 100.0 ± 20.0 | 0.10 | ||
| Neurostatus improved, n (%) | 8 (72.3%) | 4 (80.0%) | 4 (66.7%) | – | ||||||||
| CTP improved, n (%) | 40 (81.6%) | 10 (76.9%) | 26 (83.9%) | 4 (80.0%) | ||||||||
| DSA improved, n (%) | 27 (93.1%) | 11 (84.6%) | 10 (100%) | 6 (100%) | ||||||||
*
Statistically significant result.
TBA, transcutaneous balloon angioplasty; IAN, continuous intraarterial nimodipine; TCD, transcranial doppler; CTP, CT perfusion; DSA, digital subtraction angiography.